BCL2 and neoplasm: This tumor-suppressive effect involves inhibition of the NF-κB pathway, as evidenced by reduced nuclear localization of RelA and decreased expression of NF-κB target genes, including cIAP, XIAP, BCL2, and Survivin [420].